XML 27 R18.htm IDEA: XBRL DOCUMENT v3.20.4
STOCKHOLDERS EQUITY (Tables)
9 Months Ended
Jun. 30, 2020
STOCKHOLDERS EQUITY  
Stock options, stock bonuses and compensation granted by the Company

Underlying share information for equity compensation plans as of June 30, 2020 is as follows:

 

Name of Plan

 

Total Shares Reserved Under Plans

 

 

Shares Reserved for Outstanding Options

 

 

Shares Issued

 

 

Remaining Options/Shares

Under Plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Incentive Stock Options Plans

 

 

138,400

 

 

 

89,895

 

 

 

N/A

 

 

 

213

 

Non-Qualified Stock Option Plans

 

 

9,987,200

 

 

 

8,593,438

 

 

 

N/A

 

 

 

1,151,666

 

Stock Bonus Plans

 

 

783,760

 

 

 

N/A

 

 

 

341,951

 

 

 

441,776

 

Stock Compensation Plans

 

 

634,000

 

 

 

N/A

 

 

 

150,695

 

 

 

464,895

 

Incentive Stock Bonus Plan

 

 

640,000

 

 

 

N/A

 

 

 

616,500

 

 

 

23,500

 

 

Underlying share information for equity compensation plans as of September 30, 2019 is as follows:

 

Name of Plan

 

Total Shares Reserved
Under Plans

 

 

Shares Reserved for Outstanding Options

 

 

Shares
Issued

 

 

Remaining Options/Shares Under Plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Incentive Stock Option Plans

 

 

138,400

 

 

 

89,895

 

 

 

N/A

 

 

 

213

 

Non-Qualified Stock Option Plans

 

 

6,387,200

 

 

 

6,128,321

 

 

 

N/A

 

 

 

112,166

 

Stock Bonus Plans

 

 

783,760

 

 

 

N/A

 

 

 

331,226

 

 

 

452,501

 

Stock Compensation Plans

 

 

634,000

 

 

 

N/A

 

 

 

130,183

 

 

 

485,407

 

Incentive Stock Bonus Plan

 

 

640,000

 

 

 

N/A

 

 

 

616,500

 

 

 

23,500

 

Stock option activity

 

 

Nine Months Ended June 30,

 

 

 

 2020

 

 

2019

 

Granted

 

 

2,561,500

 

 

 

3,268,862

 

Exercised

 

 

94,199

 

 

 

42,770

 

Expired

 

 

1,000

 

 

 

29,322

 

Forfeited

 

 

1,180

 

 

 

63,698

 

 

 

 

Three Months Ended June 30,

 

 

 

2020

 

 

2019

 

Granted

 

 

2,559,000

 

 

 

3,268,362

 

Exercised

 

 

73,719

 

 

 

42,770

 

Expired

 

 

16

 

 

 

26,922

 

Forfeited

 

 

-

 

 

 

39,505

 

Stock-based compensation expense

 

 

Nine months Ended June 30,

 

 

 

2020

 

 

2019

 

Employees

 

$6,690,331

 

 

$2,626,311

 

Non-employees

 

$623,146

 

 

$688,070

 

 

 

 

Three months Ended June 30,

 

 

 

2020

 

 

2019

 

Employees

 

$3,109,127

 

 

$1,521,821

 

Non-employees

 

$275,919

 

 

$176,646

 

Derivative liabilities, warrants and other options

Warrant/Options

 

Issue Date

 

Shares Issuable upon Exercise

of Warrants/ Options

 

 

Exercise Price

 

 

Expiration Date

 

Reference

 

Series N

 

8/18/2008

 

 

85,339

 

 

$3.00

 

 

2/18/2021

 

 

2

 

Series XX

 

6/11/2020

 

 

461,953

 

 

$18.00

 

 

9/10/2020

 

 

2

 

Series YY

 

6/26/2020

 

 

101,839

 

 

$20.00

 

 

9/25/2020

 

 

2

 

Series UU

 

6/11/2018

 

 

93,603

 

 

$2.80

 

 

12/31/2020

 

 

2

 

Series W

 

10/28/2015

 

 

688,930

 

 

$16.75

 

 

10/28/2020

 

 

1

 

Series X

 

1/13/2016

 

 

120,000

 

 

$9.25

 

 

1/13/2021

 

*

 

Series Y

 

2/15/2016

 

 

26,000

 

 

$12.00

 

 

2/15/2021

 

*

 

Series ZZ

 

5/23/2016

 

 

20,000

 

 

$13.75

 

 

5/18/2021

 

 

1

 

Series BB

 

8/26/2016

 

 

16,000

 

 

$13.75

 

 

8/22/2021

 

 

1

 

Series Z

 

5/23/2016

 

 

264,000

 

 

$13.75

 

 

11/23/2021

 

 

1

 

Series CC

 

12/8/2016

 

 

153,643

 

 

$5.00

 

 

12/8/2021

 

 

1

 

Series HH

 

2/23/2017

 

 

200

 

 

$3.13

 

 

2/16/2022

 

 

1

 

Series AA

 

8/26/2016

 

 

200,000

 

 

$13.75

 

 

2/22/2022

 

 

1

 

Series MM

 

6/22/2017

 

 

893,491

 

 

$1.86

 

 

6/22/2022

 

*

 

Series NN

 

7/24/2017

 

 

375,545

 

 

$2.52

 

 

7/24/2022

 

 

2

 

Series OO

 

7/31/2017

 

 

-

 

 

$2.52

 

 

7/31/2022

 

 

2

 

Series RR

 

10/30/2017

 

 

457,116

 

 

$1.65

 

 

10/30/2022

 

 

2

 

Series SS

 

12/19/2017

 

 

326,064

 

 

$2.09

 

 

12/18/2022

 

 

2

 

Series TT

 

2/5/2018

 

 

371,564

 

 

$2.24

 

 

2/5/2023

 

 

2

 

Series VV

 

7/2/2018

 

 

-

 

 

$1.75

 

 

1/2/2024

 

 

2

 

Consultants

 

7/28/17

 

 

10,000

 

 

$2.18

 

 

7/27/2027

 

*

 

Tabular disclosure of derivative liabilities at fair value

 

June 30,

2020

 

 

September 30,

2019

 

Series V warrants

 

$-

 

 

$674,442

 

Series W warrants

 

 

1,808,203

 

 

 

1,193,507

 

Series Z warrants

 

 

1,852,040

 

 

 

1,109,545

 

Series ZZ warrants

 

 

115,957

 

 

 

77,638

 

Series AA warrants

 

 

1,464,362

 

 

 

916,908

 

Series BB warrants

 

 

108,586

 

 

 

63,966

 

Series CC warrants

 

 

1,666,749

 

 

 

1,710,898

 

Series FF warrants

 

 

-

 

 

 

446,185

 

Series HH warrants

 

 

2,435

 

 

 

45,657

 

Series JJ warrants

 

 

-

 

 

 

66,599

 

Series LL warrants

 

 

-

 

 

 

182,965

 

Total warrant liabilities

 

$7,018,332

 

 

$6,488,310

 

Schedule of gains and (losses) on derivative liabilities

 

 

 2020

 

 

2019

 

Series S warrants

 

$-

 

 

$33

 

Series V warrants

 

 

185,652

 

 

 

(479,399)

Series W warrants

 

 

(614,696)

 

 

(1,132,156)

Series Z warrants

 

 

(742,495)

 

 

(684,859)

Series ZZ warrants

 

 

(38,319)

 

 

(37,970)

Series AA warrants

 

 

(547,454)

 

 

(583,516)

Series BB warrants

 

 

(44,620)

 

 

(35,800)

Series CC warrants

 

 

(1,245,627)

 

 

(2,007,287)

Series DD warrants

 

 

-

 

 

 

1,249,287

 

Series EE warrants

 

 

-

 

 

 

1,249,287

 

Series FF warrants

 

 

(319,706)

 

 

(244,170)

Series GG warrants

 

 

-

 

 

 

195,228

 

Series HH warrants

 

 

(35,024)

 

 

(22,859)

Series II warrants

 

 

-

 

 

 

(593,960)

Series JJ warrants

 

 

(64,992)

 

 

(32,954)

Series KK warrants

 

 

-

 

 

 

(55,622)

Series LL warrants

 

 

(98,066)

 

 

(99,667)

Net loss on warrant liabilities

 

$(3,565,347)

 

$(3,316,384)

  

The table below presents the gains/(losses) on the warrant liabilities for the three months ended June 30:

   

 

 

 2020

 

 

 2019

 

Series V warrants

 

$107,191

 

 

$(974,251)

Series W warrants

 

 

(247,327)

 

 

(1,748,184)

Series Z warrants

 

 

(430,619)

 

 

(799,690)

Series ZZ warrants

 

 

(33,734)

 

 

(50,608)

Series AA warrants

 

 

(220,831)

 

 

(676,784)

Series BB warrants

 

 

(37,592)

 

 

(43,536)

Series CC warrants

 

 

(419,350)

 

 

(2,346,985)

Series FF warrants

 

 

-

 

 

 

(278,773)

Series GG warrants

 

 

-

 

 

 

88,478

 

Series HH warrants

 

 

(567)

 

 

(33,501)

Series II warrants

 

 

-

 

 

 

(709,303)

Series JJ warrants

 

 

-

 

 

 

(48,880)

Series KK warrants

 

 

-

 

 

 

(169,089)

Series LL warrants

 

 

-

 

 

 

(114,413)

Net loss on warrant liabilities

 

$(1,282,829)

 

$(7,905,519)
Warrants recorded as liabilities exercised

The following warrants recorded as liabilities were exercised during the periods ended June 30, 2020.

 

 

 

Three Months

 

 

Nine Months

 

Warrants

 

Warrants Exercised

 

 

Exercise Price

 

 

Proceeds

 

 

Warrants Exercised

 

 

Exercise Price

 

 

Proceeds

 

Series V

 

 

674,164

 

 

$13.75

 

 

$9,269,755

 

 

 

674,164

 

 

$13.75

 

 

$9,269,755

 

Series CC

 

 

-

 

 

 

-

 

 

 

-

 

 

 

123,820

 

 

$5.00

 

 

 

619,100

 

Series FF

 

 

-

 

 

 

-

 

 

 

-

 

 

 

68,048

 

 

$3.91

 

 

 

265,812

 

Series HH

 

 

-

 

 

 

-

 

 

 

-

 

 

 

6,300

 

 

$3.13

 

 

 

19,687

 

Series JJ

 

 

-

 

 

 

-

 

 

 

-

 

 

 

9,450

 

 

$3.13

 

 

 

29,531

 

Series LL

 

 

-

 

 

 

-

 

 

 

-

 

 

 

26,398

 

 

$3.59

 

 

 

94,867

 

 

 

 

674,164

 

 

 

 

 

 

$9,269,755

 

 

 

908,180

 

 

 

 

 

 

$10,298,752

 

The following warrants recorded as liabilities were exercised during the periods ended June 30, 2019.

 

 

 

Three Months

 

 

Nine Months

 

 

 

Warrants

 

 

Exercise

 

 

 

 

 

Warrants

 

 

Exercise

 

 

 

 

Warrants

 

Exercised

 

 

Price

 

 

Proceeds

 

 

Exercised

 

 

Price

 

 

Proceeds

 

Series CC

 

 

69,017

 

 

$

5.00

 

 

$

345,085

 

 

 

69,017

 

 

$

5.00

 

 

$

345,085

 

Series GG

 

 

200,000

 

 

$

3.00

 

 

 

600,000

 

 

 

200,000

 

 

$

3.00

 

 

 

600,000

 

Series HH

 

 

13,500

 

 

$

3.13

 

 

 

42,188

 

 

 

13,500

 

 

$

3.13

 

 

 

42,188

 

Series II

 

 

121,500

 

 

$

3.00

 

 

 

364,500

 

 

 

121,500

 

 

$

3.00

 

 

 

364,500

 

Series JJ

 

 

20,550

 

 

$

3.13

 

 

 

64,219

 

 

 

20,550

 

 

$

3.13

 

 

 

64,219

 

Series KK

 

 

213,870

 

 

$

3.04

 

 

 

649,095

 

 

 

213,870

 

 

$

3.04

 

 

 

649,095

 

 

 

 

638,437

 

 

 

 

 

 

$

2,065,087

 

 

 

638,437

 

 

 

 

 

 

$

2,065,087

 

Warrants recorded as equity exercised

The following warrants recorded as equity were exercised during the periods ended June 30, 2020.

 

 

 

 

Three Months

 

 

Nine Months

 

Warrants

 

Warrants Exercised

 

 

Exercise Price

 

 

Proceeds

 

 

Warrants Exercised

 

 

Exercise Price

 

 

Proceeds

 

Series NN

 

 

-

 

 

 

-

 

 

$-

 

 

 

98,253

 

 

$2.52

 

 

$247,598

 

Series OO

 

 

10,000

 

 

$2.52

 

 

 

25,200

 

 

 

50,000

 

 

$2.52

 

 

 

126,000

 

Series SS

 

 

39,474

 

 

$2.09

 

 

 

82,500

 

 

 

156,580

 

 

$2.09

 

 

 

327,252

 

Series TT

 

 

10,000

 

 

$2.24

 

 

 

22,400

 

 

 

188,125

 

 

$2.24

 

 

 

421,400

 

Series UU

 

 

61,207

 

 

$2.80

 

 

 

171,380

 

 

 

61,207

 

 

$2.80

 

 

 

171,380

 

Series VV

 

 

55,000

 

 

$1.75

 

 

 

96,250

 

 

 

82,500

 

 

$1.75

 

 

 

144,375

 

 

 

 

175,681

 

 

 

 

 

 

$397,730

 

 

 

636,665

 

 

 

 

 

 

$1,438,005

 

The following warrants recorded as equity were exercised during the periods ended June 30, 2019.

 

 

 

Three Months

 

 

Nine Months

 

Warrants

 

Warrants Exercised

 

 

Exercise Price

 

 

Proceeds

 

 

Warrants Exercised

 

 

Exercise Price

 

 

Proceeds

 

Series NN

 

 

65,502

 

 

$2.52

 

 

$165,065

 

 

 

65,502

 

 

$2.52

 

 

$165,065

 

Series PP

 

 

-

 

 

 

-

 

 

 

-

 

 

 

60,000

 

 

$2.30

 

 

 

138,000

 

Series QQ

 

 

3,500

 

 

$2.50

 

 

 

8,750

 

 

 

3,500

 

 

$2.50

 

 

 

8,750

 

Series RR

 

 

60,044

 

 

$1.65

 

 

 

99,073

 

 

 

60,044

 

 

$1.65

 

 

 

99,073

 

Series SS

 

 

280,264

 

 

$2.09

 

 

 

585,752

 

 

 

446,054

 

 

$2.09

 

 

 

932,253

 

Series TT

 

 

450,069

 

 

$2.24

 

 

 

1,008,155

 

 

 

536,119

 

 

$2.24

 

 

 

1,200,907

 

Series UU

 

 

24,018

 

 

$2.80

 

 

 

67,250

 

 

 

24,018

 

 

$2.80

 

 

 

67,250

 

Series VV

 

 

2,425,000

 

 

$1.75

 

 

 

4,243,750

 

 

 

3,810,000

 

 

$1.75

 

 

 

6,667,500

 

Series WW

 

 

67,275

 

 

$1.63

 

 

 

109,321

 

 

 

193,050

 

 

$1.63

 

 

 

313,705

 

 

 

 

3,375,672

 

 

 

 

 

 

$6,287,116

 

 

 

5,198,287

 

 

 

 

 

 

$9,592,503

 

Other non-operating gains and (losses) on securities purchase agreements

 

Nine Months Ended

Three Months Ended

 

 

 

June 30,2020

 

 

June 30, 2019

 

 

June 30, 2020

 

 

June 30, 2019

 

Amount realized through the resale of shares

 

$2,539,245

 

 

$3,167,197

 

 

$818,565

 

 

$1,455,844

 

Fair value of shares upon issuance

 

 

1,769,500

 

 

 

1,290,000

 

 

 

1,769,500

 

 

 

-

 

Other non-operating gain (loss)

 

$769,745

 

 

$1,877,197

 

 

$(950,935)

 

$1,455,844